23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Presentation #0062 Dec 5, 2025 from 6:15 PM to 7:45 PM PST Supporting Materials Poster: COVALENT-111: Durable Glycemic and C-Peptide Improvements Through Week 52 with Icovamenib, a Menin Inhibitor Targeting Beta-Cell Restoration in Insulin-Deficient Type 2 Diabetes 654.5 KB Presentation: COVALENT-111: Durable Glycemic and C-Peptide Improvements Through Week 52 with Icovamenib, a Menin Inhibitor Targeting Beta-Cell Restoration in Insulin-Deficient Type 2 Diabetes 1.4 MB
Poster: COVALENT-111: Durable Glycemic and C-Peptide Improvements Through Week 52 with Icovamenib, a Menin Inhibitor Targeting Beta-Cell Restoration in Insulin-Deficient Type 2 Diabetes 654.5 KB
Presentation: COVALENT-111: Durable Glycemic and C-Peptide Improvements Through Week 52 with Icovamenib, a Menin Inhibitor Targeting Beta-Cell Restoration in Insulin-Deficient Type 2 Diabetes 1.4 MB
